Management of Atrial Fibrillation in Patients With Structural Heart Disease

Therapies Friday, February 24th, 2012

American Heart Association: Feb, 21, 2012: Andrew E. Darby, MD;  John P. DiMarco, MD, PhD: Correspondence to John P. DiMarco, MD, PhD, Box 800158, Cardiovascular Division, University of Virginia Health System, Charlottesville, VA 22908.

Atrial fibrillation (AF) is the most common sustained arrhythmia encountered by clinicians. The prevalence of AF increases with age, and the elderly are the fastest growing subset of the population. It has been estimated that there will be >12 million patients with AF in the United States within the next several decades.1,2

AF may present in a wide variety of clinical conditions. The optimal management strategy for an individual patient with AF depends on the patient’s underlying condition. In some patients, AF occurs in the absence of structural heart disease. Clinical trials involving only or predominantly this type of AF may not be completely applicable to those with concomitant heart disorders. Structural heart disease may influence both the approach to management (ie, rate versus rhythm control) and the treatment options available. Read Full Article

 

National Minority Quality Forum Clinical Trial Engagement Network Map Childhood Obesity MapHIV Z-Atlas: Peripheral Arterial Disease Atlas Map Lung Cancer Index Z-Atlas: Chronic Kidney Disease AFIB Index Cardiometabolic Health Aliance Minority Diabetes Coalition U.S. Diabetes Index County Edition U.S. Diabetes Index Research Edition Medicare Index Medicare Index Stroke Edition About The Minority Stroke Working Group Hepatitis C Disease Index Lead Risk Index Map MRSA StrokePAD Minority Index The South Texas Diabetes Initiative Minority Stroke Consortium YouTube NMQF Videos IPAB Action Center National Health Index

© 2011 National Minority Quality Forum, Inc. All Rights Reserved.